Dual-responsive nano-prodrug micelles for MRI-guided tumor PDT and immune synergistic therapy

• Published in: Journal of materials chemistry. B, Materials for biology and medicine Vol. 1; no. 22; pp. 4261 - 4273
• Main Authors: Guo, Hui, Liu, Fangzhe, Liu, Enqi, Wei, Shanshan, Sun, Wenbo, Liu, Baoqiang, Sun, Guoying, Lu, Lehui
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 08.06.2022
• Subjects: Biocompatibility; Blood circulation; Cancer; Conjugation; Drug delivery; Drug delivery systems; Gadolinium; Humans; Immunosuppressive agents; Magnetic Resonance Imaging; Micelles; Neoplasms - diagnostic imaging; Neoplasms - drug therapy; pH effects; Photochemotherapy; Photodynamic therapy; Polymers; Prodrugs; Prodrugs - chemistry; Triazenes; Tryptophan 2,3-dioxygenase; Tumor Microenvironment; Tumors
• ISSN: 2050-750X; 2050-7518
• DOI: 10.1039/d1tb02790e

Micelles as nanocarriers not only offer new opportunities for early diagnosis and treatment of malignant cancers but also encounter numerous barriers in the path of efficient delivery of drugs to diseased areas in the body. To address these issues, we developed a pH/GSH responsive nano-prodrug micelle (NLG919/PGA-Cys-PPA@Gd) with a high drug-loading ratio and controlled drug release performance for MRI-guided tumor photodynamic therapy (PDT) and immune synergistic therapy. Under normal conditions, theranostic nanomicelles remained stable and in a photo-quenched state. Upon accumulation in the tumor site, however, the micelles demonstrated tumor microenvironment (TME) triggered photoactive formed-PPA (a photosensitizer) and NLG919 (an indoleamine 2,3-dioxygenase (IDO) inhibitor) release because the amide bonds of PGA-Cys-PPA and the disulfide linkage of Cys were sensitive to pH and GSH, respectively. More importantly, these micelles could avoid the undesired PPA leakage in blood circulation due to the conjugation between PPA and polymers. Furthermore, the obtained micelles could also enhance the contrast of T 1 -weighted MRI of tumors by virtue of their high relaxivity ( r 1 = 29.85 mM −1 s −1 ). In vitro and in vivo results illustrated that the micelles had good biocompatibility and biosafety. On the basis of the efficient drug delivery strategies in PDT and IDO pathway inhibition, this intelligent dual-drug delivery system could serve as an effective approach for MRI guided combination therapy of cancer. We developed a pH/GSH responsive nano-prodrug micelle (NLG919/PGA-Cys-PPA@Gd) with a high drug-loading ratio and controlled drug release performance for MRI-guided tumor photodynamic therapy and immune synergistic therapy.